• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic studies of immunoligocal function using sphingolipid-deficient mice

Research Project

Project/Area Number 24570145
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Functional biochemistry
Research InstitutionAzabu University

Principal Investigator

YAMASHITA Tadashi  麻布大学, 獣医学部, 教授 (30220338)

Project Period (FY) 2012-04-01 – 2015-03-31
Project Status Completed (Fiscal Year 2014)
Budget Amount *help
¥5,590,000 (Direct Cost: ¥4,300,000、Indirect Cost: ¥1,290,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
Keywordsスフィンゴ脂質 / 遺伝子改変動物 / モデルマウス / スフィンゴ糖脂質 / ノックアウトマウス
Outline of Final Research Achievements

T cell specific deletion using gene deficient mice of sphingolipids demonstrated the complete loss of them in peripheral blood stream. Previous studies demonstrated that GM3 knockout mice showed rheumatism become early onset and aggravated. The total deletion of sphingolipids and GM3, one molecule of sphingolipids showed little difference. On the other hand, a remarkable difference was observed in the colitis model mice. This suggests that amount of ceramide and ceramide-derivatives in cytoplasm participate colitis resistant phenotype of sphingolipids-dificient mice.

Report

(4 results)
  • 2014 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • 2012 Research-status Report
  • Research Products

    (5 results)

All 2014 2013

All Journal Article (5 results) (of which Peer Reviewed: 5 results,  Open Access: 2 results)

  • [Journal Article] Inhibition of GM3 synthase attenuates neuropathology of niemann-pick disease type C by affecting sphingolipid metabolism.2014

    • Author(s)
      Lee. H., Lee. JK., Bae. YC., Yang. SH., Okino. N., Schuchman. EH., Yamashita. T., Bae. JS., Jin. HK.
    • Journal Title

      Mol Cells.

      Volume: 37 Pages: 161-171

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Depletion of gangliosides enhances cartilage degradation in mice.2014

    • Author(s)
      Sasazawa F, Onodera T, Yamashita T, Seito N, Tsukuda Y, Fujitani N, Shinohara Y, Iwasaki N.
    • Journal Title

      Osteoarthritis Cartilage.

      Volume: 22 Pages: 313-322

    • Related Report
      2014 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Depletion of gangliosides enhances cartilage degradation in mice.2014

    • Author(s)
      Sasazawa F, Onodera T, Yamashita T, Seito N, Tsukuda Y, Fujitani N, Shinohara Y, Iwasaki N.
    • Journal Title

      Osteoarthritis Cartilage.

      Volume: 22(2) Pages: 313-22

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Improvement of spontaneous alternation behavior deficit by activation of α4β2 nicotinic acetylcholine receptor signaling in the ganglioside GM3-deficient mice.2013

    • Author(s)
      Niimi, K., Nishioka, C., Miyamoto, T., Takahashi, E,. Miyoshi I., Itakura, C., Yamashita, T.
    • Journal Title

      Biomed Res

      Volume: 34(4) Pages: 189-195

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Journal Article] Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes.2013

    • Author(s)
      Yoon JH, Jung SM, Park SH, Kato M, Yamashita T, Lee IK, Sudo K, Nakae S, Han JS, Kim OH, Oh BC, Sumida T, Kuroda M, Ju JH, Jung KC, Park SH, Kim DK, Mamura M.
    • Journal Title

      EMBO Mol Med.

      Volume: 5(11) Pages: 1720-39

    • Related Report
      2013 Research-status Report
    • Peer Reviewed

URL: 

Published: 2013-05-31   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi